Erlotinib Terminated Phase 2 Trials for Malignancies Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01518621Whole Brain Radiation With or Without Erlotinib for Brain Metastases From Non-Small Cell Lung Cancer
NCT01376310GSK1120212 Rollover Study